BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Caparello C, Meijer LL, Garajova I, Falcone A, Le Large TY, Funel N, Kazemier G, Peters GJ, Vasile E, Giovannetti E. FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancer. World J Gastroenterol 2016; 22(31): 6987-7005 [PMID: 27610011 DOI: 10.3748/wjg.v22.i31.6987]
URL: https://www.wjgnet.com/1007-9327/full/v22/i31/6987.htm
Number Citing Articles
1
Aurélien Lambert, Céline Gavoille, Thierry Conroy. Current status on the place of FOLFIRINOX in metastatic pancreatic cancer and future directionsTherapeutic Advances in Gastroenterology 2017; 10(8): 631 doi: 10.1177/1756283X17713879
2
Ingrid Hilger. Magnetic Materials and Technologies for Medical Applications2022; : 265 doi: 10.1016/B978-0-12-822532-5.00018-2
3
Dimitrios Stefanoudakis, Maximos Frountzas, Dimitrios Schizas, Nikolaos V. Michalopoulos, Alexandra Drakaki, Konstantinos G. Toutouzas. Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic CancerCurrent Issues in Molecular Biology 2024; 46(4): 2827 doi: 10.3390/cimb46040177
4
Btissame El Hassouni, Giovanna Li Petri, Daniel S.K. Liu, Stella Cascioferro, Barbara Parrino, Waqar Hassan, Patrizia Diana, Asif Ali, Adam E Frampton, Elisa Giovannetti. Pharmacogenetics of treatments for pancreatic cancerExpert Opinion on Drug Metabolism & Toxicology 2019; 15(6): 437 doi: 10.1080/17425255.2019.1620731
5
Tessa Ya Sung Le Large, Btissame El Hassouni, Geert Kazemier, Sander R. Piersma, Hanneke W. M. van Laarhoven, Maarten F. Bijlsma, Cornelia R. Jimenez, Elisa Giovannetti. Multidrug‐resistant transporter expression does not always result in drug resistanceCancer Science 2018; 109(10): 3360 doi: 10.1111/cas.13756
6
Jisce R Puik, Laura L Meijer, Tessa YS Le Large, Mireia Mato Prado, Adam E Frampton, Geert Kazemier, Elisa Giovannetti. miRNA Profiling for Diagnosis, Prognosis and Stratification of Cancer Treatment in CholangiocarcinomaPharmacogenomics 2017; 18(14): 1343 doi: 10.2217/pgs-2017-0010
7
Neal Bhutiani, Yan Li, Qianqian Zheng, Harshul Pandit, Xiaoju Shi, Yujia Chen, Youxi Yu, Zachary R. Pulliam, Min Tan, Robert C. G. Martin. Electrochemotherapy with Irreversible Electroporation and FOLFIRINOX Improves Survival in Murine Models of Pancreatic AdenocarcinomaAnnals of Surgical Oncology 2020; 27(11): 4348 doi: 10.1245/s10434-020-08782-2
8
T.Y.S. Le Large, M.F. Bijlsma, G. Kazemier, H.W.M. van Laarhoven, E. Giovannetti, C.R. Jimenez. Key biological processes driving metastatic spread of pancreatic cancer as identified by multi-omics studiesSeminars in Cancer Biology 2017; 44: 153 doi: 10.1016/j.semcancer.2017.03.008
9
Tessa Y.S. Le Large, Laura L. Meijer, Rosita Paleckyte, Lenka N.C. Boyd, Bart Kok, Thomas Wurdinger, Tim Schelfhorst, Sander R. Piersma, Thang V. Pham, Nicole C.T. van Grieken, Barbara M. Zonderhuis, Freek Daams, Hanneke W.M. van Laarhoven, Maarten F. Bijlsma, Connie R. Jimenez, Elisa Giovannetti, Geert Kazemier. Combined Expression of Plasma Thrombospondin-2 and CA19-9 for Diagnosis of Pancreatic Cancer and Distal Cholangiocarcinoma: A Proteome ApproachThe Oncologist 2020; 25(4): e634 doi: 10.1634/theoncologist.2019-0680
10
Monique Williams, Gwen Lomberk, Raul Urrutia. Pancreatic Cancer2017; : 1 doi: 10.1007/978-1-4939-6631-8_15-2
11
Btissame El Hassouni, Giulia Mantini, Benoît Immordino, Godefridus J. Peters, Elisa Giovannetti. CX-5461 Inhibits Pancreatic Ductal Adenocarcinoma Cell Growth, Migration and Induces DNA DamageMolecules 2019; 24(24): 4445 doi: 10.3390/molecules24244445
12
Guido Giordano, Massimo Pancione, Nunzio Olivieri, Pietro Parcesepe, Marianna Velocci, Tania Di Raimo, Luigi Coppola, Giuseppe Toffoli, Mario Rosario D’Andrea. Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directionsWorld Journal of Gastroenterology 2017; 23(32): 5875-5886 doi: 10.3748/wjg.v23.i32.5875
13
Mjriam Capula, Macarena Perán, Geng Xu, Valentina Donati, Dicky Yee, Alessandro Gregori, Yehuda G. Assaraf, Elisa Giovannetti, Dongmei Deng. Role of drug catabolism, modulation of oncogenic signaling and tumor microenvironment in microbe-mediated pancreatic cancer chemoresistanceDrug Resistance Updates 2022; 64: 100864 doi: 10.1016/j.drup.2022.100864
14
Rosa Wijnen, Camilla Pecoraro, Daniela Carbone, Hamid Fiuji, Amir Avan, Godefridus J. Peters, Elisa Giovannetti, Patrizia Diana. Cyclin Dependent Kinase-1 (CDK-1) Inhibition as a Novel Therapeutic Strategy against Pancreatic Ductal Adenocarcinoma (PDAC)Cancers 2021; 13(17): 4389 doi: 10.3390/cancers13174389
15
Yongheng Shu, Ping Cheng. Targeting tumor-associated macrophages for cancer immunotherapyBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1874(2): 188434 doi: 10.1016/j.bbcan.2020.188434
16
Akhileshwar Kumar Srivastava, Dhruv Kumar, Divya Singh, Rajesh Kumar Singh. Xenobiotics in Chemical Carcinogenesis2022; : 245 doi: 10.1016/B978-0-323-90560-2.00011-X
17
Rong-Jane Chen, Yi-Jhen Lyu, Yu-Ying Chen, Yen-Chien Lee, Min-Hsiung Pan, Yuan-Soon Ho, Ying-Jan Wang. Chloroquine Potentiates the Anticancer Effect of Pterostilbene on Pancreatic Cancer by Inhibiting Autophagy and Downregulating the RAGE/STAT3 PathwayMolecules 2021; 26(21): 6741 doi: 10.3390/molecules26216741
18
Lorenzo Fornaro, Francesco Leone, Angélique Vienot, Andrea Casadei-Gardini, Caterina Vivaldi, Astrid Lièvre, Pasquale Lombardi, Emmanuele De Luca, Dewi Vernerey, Elisa Sperti, Gianna Musettini, Maria Antonietta Satolli, Julien Edeline, Rosella Spadi, Cindy Neuzillet, Alfredo Falcone, Giulia Pasquini, Mario Clerico, Alessandro Passardi, Paola Buscaglia, Aurélia Meurisse, Massimo Aglietta, Clémence Brac, Enrico Vasile, Francesco Montagnani. Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and IrinotecanClinical Colorectal Cancer 2019; 18(4): e394 doi: 10.1016/j.clcc.2019.08.004
19
Mahrou Vahabi, Geng Xu, Amir Avan, Godefridus J. Peters, Elisa Giovannetti. Pharmacological mechanisms underlying the interaction of the nucleoside analogue gemcitabine with the c-MET inhibitor tivantinib in pancreatic cancerNucleosides, Nucleotides & Nucleic Acids 2024; : 1 doi: 10.1080/15257770.2024.2319215
20
Kang Chen, Manxiong Dai, Quanneng Luo, Yi Wang, Weitao Shen, Yan Liao, Yiying Zhou, Wei Cheng. PARP1 controls the transcription of CD24 by ADP-ribosylating the RNA helicase DDX5 in pancreatic cancerThe International Journal of Biochemistry & Cell Biology 2023; 155: 106358 doi: 10.1016/j.biocel.2022.106358
21
Wei Sun, Yong Zhang, Xiaolu Ren, Lingzhi Cui, Jianguo Wang, Xiaohong Ni. <i>In Silico</i> Studies, Biological Activities, and Anti-human Pancreatic Cancer Potential of 6-Hydroxy-4-methylcoumarin and 2,5-Dihydroxyacetophenone as Flavonoid CompoundsJournal of Oleo Science 2022; 71(6): 853 doi: 10.5650/jos.ess22021
22
Chiara Deiana, Margherita Agostini, Giovanni Brandi, Elisa Giovannetti. The trend toward more target therapy in pancreatic ductal adenocarcinomaExpert Review of Anticancer Therapy 2024; : 1 doi: 10.1080/14737140.2024.2357802
23
Ornella Randazzo, Filippo Papini, Giulia Mantini, Alessandro Gregori, Barbara Parrino, Daniel S. K. Liu, Stella Cascioferro, Daniela Carbone, Godefridus J. Peters, Adam E. Frampton, Ingrid Garajova, Elisa Giovannetti. “Open Sesame?”: Biomarker Status of the Human Equilibrative Nucleoside Transporter-1 and Molecular Mechanisms Influencing its Expression and Activity in the Uptake and Cytotoxicity of Gemcitabine in Pancreatic CancerCancers 2020; 12(11): 3206 doi: 10.3390/cancers12113206
24
Xi Cheng, Bingrui Wang, Zhijian Jin, Ding Ma, Weiping Yang, Ren Zhao, Xiaoqian Jing, Baiyong Shen, Chenghong Peng, Weihua Qiu. Pseudomonas aeruginosa-mannose-sensitive hemagglutinin inhibits pancreatic cancer cell proliferation and induces apoptosis via the EGFR pathway and caspase signalingOncotarget 2016; 7(47): 77916 doi: 10.18632/oncotarget.12844
25
Nele Van Der Steen, Ingrid Garajova, Christian Rolfo, Andrea Cavazzoni, Elisa Giovannetti. Targeting Cell Survival Pathways to Enhance Response to Chemotherapy2019; : 25 doi: 10.1016/B978-0-12-813753-6.00002-0
26
Isaac James Muyinda, Jae-Gwang Park, Eun-Jung Jang, Byong-Chul Yoo. KRAS, A Prime Mediator in Pancreatic Lipid Synthesis through Extra Mitochondrial Glutamine and Citrate MetabolismInternational Journal of Molecular Sciences 2021; 22(10): 5070 doi: 10.3390/ijms22105070
27
Monique Williams, Gwen Lomberk, Raul Urrutia. Pancreatic Cancer2018; : 383 doi: 10.1007/978-1-4939-7193-0_15
28
Annalisa Comandatore, Benoit Immordino, Rita Balsano, Mjriam Capula, Ingrid Garajovà, Joseph Ciccolini, Elisa Giovannetti, Luca Morelli. Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic CancerDiagnostics 2022; 12(2): 286 doi: 10.3390/diagnostics12020286
29
Theodoros Michelakos, Cristina R. Ferrone. Pancreatic Cancer2018; : 1187 doi: 10.1007/978-1-4939-7193-0_93
30
Ingrid Garajová, Rita Balsano, Heling Wang, Francesco Leonardi, Elisa Giovannetti, Dongmei Deng, Godefridus J. Peters. The role of the microbiome in drug resistance in gastrointestinal cancersExpert Review of Anticancer Therapy 2021; 21(2): 165 doi: 10.1080/14737140.2021.1844007
31
Ingrid Garajová, Rita Balsano, Chiara Tommasi, Elisa Giovannetti. Noncoding Rnas Emerging as Novel Biomarkers in Pancreatic CancerCurrent Pharmaceutical Design 2019; 24(39): 4601 doi: 10.2174/1381612825666190119125804
32
E. Giovannetti, C.L. van der Borden, A.E. Frampton, A. Ali, O. Firuzi, G.J. Peters. Never let it go: Stopping key mechanisms underlying metastasis to fight pancreatic cancerSeminars in Cancer Biology 2017; 44: 43 doi: 10.1016/j.semcancer.2017.04.006
33
A. N. Khitrova, L. V. Bolotina, A. L. Kornietskaya, L. I. Moskvicheva. High-intensity focused ultrasound therapy as part of combined treatment for inoperable pancreatic cancerOnkologiya. Zhurnal imeni P.A.Gertsena 2020; 9(1): 50 doi: 10.17116/onkolog2020901150
34
Benjamin A. Krantz, Eileen M. O'Reilly. Biomarker-Based Therapy in Pancreatic Ductal Adenocarcinoma: An Emerging Reality?Clinical Cancer Research 2018; 24(10): 2241 doi: 10.1158/1078-0432.CCR-16-3169
35
Mahrou Vahabi, Annalisa Comandatore, Chiara Centra, Giovanni Blandino, Luca Morelli, Elisa Giovannetti. Thinking small to win big? A critical review on the potential application of extracellular vesicles for biomarker discovery and new therapeutic approaches in pancreatic cancerSeminars in Cancer Biology 2023; 97: 50 doi: 10.1016/j.semcancer.2023.11.003
36
Camilla Pecoraro, Barbara Parrino, Stella Cascioferro, Adrian Puerta, Amir Avan, Godefridus J. Peters, Patrizia Diana, Elisa Giovannetti, Daniela Carbone. A New Oxadiazole-Based Topsentin Derivative Modulates Cyclin-Dependent Kinase 1 Expression and Exerts Cytotoxic Effects on Pancreatic Cancer CellsMolecules 2021; 27(1): 19 doi: 10.3390/molecules27010019
37
Mahrou Vahabi, Bilal Dehni, Inés Antomás, Elisa Giovannetti, Godefridus J. Peters. Targeting miRNA and using miRNA as potential therapeutic options to bypass resistance in pancreatic ductal adenocarcinomaCancer and Metastasis Reviews 2023; 42(3): 725 doi: 10.1007/s10555-023-10127-w
38
Daniel Ansari, Fredrik Sambergs, Love Johansson, Roland Andersson. Can protein science solve the unmet needs in pancreatic cancer diagnosis and therapy?Expert Review of Proteomics 2017; 14(6): 469 doi: 10.1080/14789450.2017.1314787
39
John P. Neoptolemos, David Cunningham, Francesco Sclafani, Paula Ghaneh. Pancreatic Cancer2018; : 1039 doi: 10.1007/978-1-4939-7193-0_43
40
Haiyang Du, Gao Si, Jiqing Si, Xuejie Song, Fuchun Si. Single-cell RNA sequencing analysis revealed malignant ductal cell heterogeneity and prognosis signatures in pancreatic cancerClinics and Research in Hepatology and Gastroenterology 2023; 47(8): 102200 doi: 10.1016/j.clinre.2023.102200
41
Theodoros Michelakos, Cristina R. Ferrone. Pancreatic Cancer2017; : 1 doi: 10.1007/978-1-4939-6631-8_93-1
42
Zhengjun Lin, Shiyao Lu, Xubin Xie, Xuyang Yi, He Huang. Noncoding RNAs in drug-resistant pancreatic cancer: A reviewBiomedicine & Pharmacotherapy 2020; 131: 110768 doi: 10.1016/j.biopha.2020.110768
43
Heike Loeser, Dirk Waldschmidt, Fabian Kuetting, Carina Heydt, Thomas Zander, Patrick Plum, Hakan Alakus, Reinhard Buettner, Alexander Quaas. Copy-number variation and protein expression of DOT1L in pancreatic adenocarcinoma as a potential drug targetMolecular and Clinical Oncology 2017; 6(5): 639 doi: 10.3892/mco.2017.1194
44
Laura L. Meijer, Ingrid Garajová, Chiara Caparello, Tessa Y. S. Le Large, Adam E. Frampton, Enrico Vasile, Niccola Funel, Geert Kazemier, Elisa Giovannetti. Plasma miR-181a-5p Downregulation Predicts Response and Improved Survival After FOLFIRINOX in Pancreatic Ductal AdenocarcinomaAnnals of Surgery 2020; 271(6): 1137 doi: 10.1097/SLA.0000000000003084
45
Michael Orth, Philipp Metzger, Sabine Gerum, Julia Mayerle, Günter Schneider, Claus Belka, Maximilian Schnurr, Kirsten Lauber. Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approachesRadiation Oncology 2019; 14(1) doi: 10.1186/s13014-019-1345-6
46
Woonghee Lee, Gwonhwa Song, Hyocheol Bae. Matairesinol Induces Mitochondrial Dysfunction and Exerts Synergistic Anticancer Effects with 5-Fluorouracil in Pancreatic Cancer CellsMarine Drugs 2022; 20(8): 473 doi: 10.3390/md20080473
47
Motahareh Mortazavi, Elaheh Raufi, Tahereh Damghani, Mehdi Khoshneviszadeh, Najmeh Edraki, Masoomeh Eskandari, Elisa Giovannetti, Godefridus J. Peters, Somayeh Pirhadi, Omidreza Firuzi. Discovery of anticancer agents with c-Met inhibitory potential by virtual and experimental screening of a chemical libraryEuropean Journal of Pharmacology 2023; 938: 175395 doi: 10.1016/j.ejphar.2022.175395
48
Ingrid Garajová, Marianna Peroni, Fabio Gelsomino, Francesco Leonardi. A Simple Overview of Pancreatic Cancer Treatment for Clinical OncologistsCurrent Oncology 2023; 30(11): 9587 doi: 10.3390/curroncol30110694
49
Muhammad Babar Jamshed, Fahad Munir, Numan Shahid, Ussama Sadiq, Syed Aun Muhammad, Noor Bader Ghanem, Hong Zhong, Xiaokun Li, Qiyu Zhang. Antitumor activity and combined inhibitory effect of ceritinib with gemcitabine in pancreatic cancerAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 318(1): G109 doi: 10.1152/ajpgi.00130.2019
50
Stella Cascioferro, Giovanna Li Petri, Barbara Parrino, Btissame El Hassouni, Daniela Carbone, Vincenzo Arizza, Ugo Perricone, Alessandro Padova, Niccola Funel, Godefridus J. Peters, Girolamo Cirrincione, Elisa Giovannetti, Patrizia Diana. 3-(6-Phenylimidazo [2,1-b][1,3,4]thiadiazol-2-yl)-1H-Indole Derivatives as New Anticancer Agents in the Treatment of Pancreatic Ductal AdenocarcinomaMolecules 2020; 25(2): 329 doi: 10.3390/molecules25020329
51
Pan Liu, Jiarui Feng, Meng Sun, Wen Yuan, Ruijing Xiao, Jie Xiong, Xiaoxin Huang, Meng Xiong, Wu Chen, Xin Yu, Qian Sun, Xiaojie Zhao, Qiuping Zhang, Liang Shao. Synergistic effects of baicalein with gemcitabine or docetaxel on the proliferation, migration and apoptosis of pancreatic cancer cellsInternational Journal of Oncology 2017; 51(6): 1878 doi: 10.3892/ijo.2017.4153
52
Marika Franczak, Barbara Kutryb-Zajac, Btissame El Hassouni, Elisa Giovannetti, Carlotta Granchi, Filippo Minutolo, Ryszard T. Smolenski, Godefridus J. Peters. The effect of lactate dehydrogenase-A inhibition on intracellular nucleotides and mitochondrial respiration in pancreatic cancer cellsNucleosides, Nucleotides & Nucleic Acids 2022; 41(12): 1375 doi: 10.1080/15257770.2022.2031215
53
Arthur T.F. Choy, Ilaria Carnevale, Stefano Coppola, Laura L. Meijer, Geert Kazemier, Egija Zaura, Dongmei Deng, Elisa Giovannetti. The microbiome of pancreatic cancer: from molecular diagnostics to new therapeutic approaches to overcome chemoresistance caused by metabolic inactivation of gemcitabineExpert Review of Molecular Diagnostics 2018; 18(12): 1005 doi: 10.1080/14737159.2018.1544495
54
Laura L. Meijer, Jisce R. Puik, Tessa Y.S. Le Large, Michal Heger, Frederike Dijk, Niccola Funel, Thomas Wurdinger, Ingrid Garajová, Nicole C.T. van Grieken, Mark A. van de Wiel, Elisa Giovannetti, Geert Kazemier. Unravelling the Diagnostic Dilemma: A MicroRNA Panel of Circulating MiR-16 and MiR-877 as A Diagnostic Classifier for Distal Bile Duct TumorsCancers 2019; 11(8): 1181 doi: 10.3390/cancers11081181
55
John P. Neoptolemos, David Cunningham, Francesco Sclafani, Paula Ghaneh. Pancreatic Cancer2016; : 1 doi: 10.1007/978-1-4939-6631-8_43-2
56
Pei Pei Che, Alessandro Gregori, Cecilia Bergonzini, Mahsoem Ali, Giulia Mantini, Thomas Schmidt, Francesco Finamore, Stephanie M. Fraga Rodrigues, Adam E. Frampton, Liam A. McDonnell, Erik H. Danen, Ben J. Slotman, Peter Sminia, Elisa Giovannetti. Differential Sensitivity to Ionizing Radiation in Gemcitabine-Resistant and Paclitaxel-Resistant Pancreatic Cancer CellsInternational Journal of Radiation Oncology*Biology*Physics 2024; 118(5): 1328 doi: 10.1016/j.ijrobp.2023.10.035
57
Ahmed F. Salem, Luca Gambini, Parima Udompholkul, Carlo Baggio, Maurizio Pellecchia. Therapeutic Targeting of Pancreatic Cancer via EphA2 Dimeric Agonistic AgentsPharmaceuticals 2020; 13(5): 90 doi: 10.3390/ph13050090
58
Alessandro Gregori, Cecilia Bergonzini, Mjriam Capula, Giulia Mantini, Fatemeh Khojasteh-Leylakoohi, Annalisa Comandatore, Ghazaleh Khalili-Tanha, Alireza Khooei, Luca Morelli, Amir Avan, Erik H. Danen, Thomas Schmidt, Elisa Giovannetti. Prognostic Significance of Integrin Subunit Alpha 2 (ITGA2) and Role of Mechanical Cues in Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma (PDAC)Cancers 2023; 15(3): 628 doi: 10.3390/cancers15030628
59
Cristoforo Grasso, Gerrit Jansen, Elisa Giovannetti. Drug resistance in pancreatic cancer: Impact of altered energy metabolismCritical Reviews in Oncology/Hematology 2017; 114: 139 doi: 10.1016/j.critrevonc.2017.03.026
60
Paul Noordhuis, Adrianus C. Laan, Kasper van de Born, Richard J. Honeywell, Godefridus J. Peters. Coexisting Molecular Determinants of Acquired Oxaliplatin Resistance in Human Colorectal and Ovarian Cancer Cell LinesInternational Journal of Molecular Sciences 2019; 20(15): 3619 doi: 10.3390/ijms20153619
61
Camilla Pecoraro, Beatrice Faggion, Beatrice Balboni, Daniela Carbone, Godefridus J. Peters, Patrizia Diana, Yehuda G. Assaraf, Elisa Giovannetti. GSK3β as a novel promising target to overcome chemoresistance in pancreatic cancerDrug Resistance Updates 2021; 58: 100779 doi: 10.1016/j.drup.2021.100779